Featured
-
Breaking News | Promotions & Moves
Eisai Appoints Chief Clinical Officer of Oncology Biz
Dr. Richard Woodman has 18 years of pharmaceutical experience in several different functional areas at both large and small biotech organizations.Contract Pharma Staff 01.20.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
Nexelis Acquires GSK Vax Lab in Marburg
Enters into a 5-year strategic agreement to support the development of future GSK vaccine candidates.Contract Pharma Staff 01.20.21
-
Clinical Trials
The Future of Clinical Trials Series: Part I
What will 2021 have in store for an industry in flux?Alison Holland, Head of Decentralized Trials, Medable, Maria Fotiu, Executive Director of Decentralized Solutions, Syneos Health 01.19.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
Enter an agreement for a process development partnership.Contract Pharma Staff 01.19.21
-
Breaking News | Industry News
NovaQuest Private Equity Acquires CoreRx
New strategic financial sponsor to support continued growth and capability expansion.Contract Pharma Staff 01.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
JS Bio and Etta Biotech Advancing Partnership
Will set up a high titer transient protein expression platform for high quality protein production.Contract Pharma Staff 01.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Intravacc Completes Project for Provention Bio’s Vax Candidate
Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.Contract Pharma Staff 01.19.21
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules
NextPharma to acquire sites in France and UK specialized in lipid oral finished dosage forms.Contract Pharma Staff 01.19.21
-
Drug Development
Drug Development For Startups
There is no way to eliminate the risk of failure. However, there are ways to reduce these risks. Learn more in this whitepaper from Recipharm.
-
Breaking News | Collaborations & Alliances | Drug Discovery
Metrion, LifeArc Extend Neuroscience Alliance
Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.Contract Pharma Staff 01.18.21
-
Breaking News | Clinical Trials | Industry News
Grifols Begins COVID-19 Plasma Treatment Trial
Treatment could be used for people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease, complementing the vaccine.Contract Pharma Staff 01.18.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Janssen, TenNor Enter NTM Research Pact
To leverage TenNor’s multitargeting drug conjugation platform to discover new therapies to treat nontuberculous mycobacteria diseases.Contract Pharma Staff 01.18.21
-
Breaking News | Industry News
KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
New lineup aims to address challenges from early stage powder characterization and formulation development to scale-up and production.Contract Pharma Staff 01.15.21
-
Clinical Trials | Drug Development | Information Technology
Virtual Clinical Trials: The Future of Dermatology Studies
COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Cognate BioServices Announces Major Expansion
Will increase cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities and more.Contract Pharma Staff 01.15.21
- Grifols Begins COVID-19 Plasma Treatment Trial
- iosBio Inks Exclusive Vax Platform Pact for COVID-19
- Baxter, Novavax Ink Sterile Manufacturing Agreement
- Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
- AMRI Included in BARDA CDMO Network
- CureVac and Bayer Join Forces
- Botanical Solution Inc. to Supply Pharma Grade QS-21 Vaccine Adjuvant
- Akston Biosciences and LakePharma Enter Covid-19 Partnership
- The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
- INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
- Global Biosciences Co. Selects ValGenesis VLMS
- Eisai Appoints Chief Clinical Officer of Oncology Biz
- Nexelis Acquires GSK Vax Lab in Marburg
- Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
- NovaQuest Private Equity Acquires CoreRx
- JS Bio and Etta Biotech Advancing Partnership
- Intravacc Completes Project for Provention Bio’s Vax Candidate
- Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules
- Valeo Pharma Appoints President, COO
- Metrion, LifeArc Extend Neuroscience Alliance
November/December 2020
- Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
- Ensuring Quality During the Transfer and Scale Up of Rx Drugs
- Inspecting the Unexpected
- Cold Chain Trends
- Catering for the Complex
- Biopharma Contract Manufacturing: Robust Growth Ahead
- DCAT President Talks COVID-19, Drug Manufacturing and Innovation
- The Single-Use Mixing Landscape: Evaluating Your Options
- Self-Medication: Flexibility for Patients and Drug Manufacturers
- Decentralized Trials Fuel AI Revolution in Clinical Research
Contract Service Directory
Search the Directories for A Company:
